MyoKardia, Inc. (NASDAQ:MYOK) notched a move of 2.85% to $64.9 for the day. The total traded volume was 412604. The stock had closed at $63.1 on the previous day.
MyoKardia, Inc. is with Insider ownership of 0.60% and institutional ownership counts to 89.20%. Shares float is 34.40M and outstanding shares are at 40.91M. The float short is currently 7.12% and short ratio is 7.79.
MyoKardia, Inc. (NASDAQ:MYOK) has disclosed insider trading transaction to the Securities and Exchange Commission (SEC). The Lee June; See Remarks of MyoKardia, Inc. sold 5000 shares at value of $63.13 on 21 Sep 2018. The Insider selling transaction had a total value worth of $315652. After the selling activity, now Lee June directly owns 426 shares of the company’s stock, valued at approximately $27647.4. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing on 24 Sep 2018.
MyoKardia, Inc.’s insider Semigran Marc sold 3600 shares of the stock in a negotiation that occurred on 05 Sep 2018. The stock was sold at an average cost of S 60 per share, for a total transaction worth of $ 216000. The sale was disclosed in a legal filing with the Securities & Exchange Commission, on 06 Sep 2018.
In related news, Semigran Marc Chief Medical Officer sold 41400 shares of the firm’s stock in a transaction that recorded on 04 Sep 2018. The stock was sold at an average price of $ 59.49 for a total value of $ 2463006. After the negotiation, now Insider holds 0 shares of the company’s stock, valued at approximately $ 0.
GIANAKAKOS ANASTASIOS President and CEO at MyoKardia, Inc. also sold 3000 on 04 Sep 2018 at an average price of $ 59.33 for a total value of $ 178004. After the transaction, GIANAKAKOS ANASTASIOS owns 74949 shares of the company’s stock, now priced at approximately $ 4864190.1. . The disclosure for this transaction can be found in SEC Form 4 submitted on 06 Sep 2018.
The stock made income -57.80M on sales of 23.20M. ROA sticks to -18.20% and ROI is -20.60%. Shares have moved -2.48% from its 1 Year high price and changed 97.87% from its 1 Year low price. The shares registered RSI (14) at 60.88 and ATR factor was seen at 2.58.